Skip to main navigation Skip to search Skip to main content

Novel aptamer to Von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab

  • Kazuya Sakai
  • , Tatsuhiko Someya
  • , Kaori Harada
  • , Hideo Yagi
  • , Taei Matsui
  • , Masanori Matsumoto

Research output: Contribution to journal › Article › peer-review

36   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Novel aptamer to Von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology